Chinese companies’ seemingly remarkable progress has them leading the race for a coronavirus vaccine. Their speedy ascent has been unhindered by common scientific setbacks being reported by Western rivals, however, raising questions about how stringently they’re vetting results and reporting potential safety issues.
China has the largest number of candidates in late-stage vaccine trials, and its shots could be used by millions worldwide because President Xi Jinping has pledged to share successful ones overseas. But there is concern about Chinese developers’ standards and safeguards because some of their vaccines are being distributed in the country under an emergency use program before getting full regulatory approval.
AstraZeneca Plc and Johnson & Johnson temporarily halted testing earlier this year in the U.K. and the U.S., respectively, after a single participant in each trial got sick. In contrast, China’s science ministry has said its companies have inoculated about 60,000 volunteers in final-stage trials, but there have been no reports of serious adverse events.
One front-runner, China National Biotec Group Co., has said it’s vaccinated hundreds of thousands of people under the emergency use program, a sign of how widely Chinese shots are being administered without reports of serious adverse events. Yet scientists say the discovery of health problems is inevitable when so many people of all ages and with varying conditions are tested—even if the vaccine isn’t causing the illness.
This story is from the {{IssueName}} edition of {{MagazineName}}.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the {{IssueName}} edition of {{MagazineName}}.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
Instagram's Founders Say It's Time for a New Social App
The rise of AI and the fall of Twitter could create opportunities for upstarts
Running in Circles
A subscription running shoe program aims to fight footwear waste
What I Learned Working at a Hawaiien Mega-Resort
Nine wild secrets from the staff at Turtle Bay, who have to manage everyone from haughty honeymooners to go-go-dancing golfers.
How Noma Will Blossom In Kyoto
The best restaurant in the world just began its second pop-up in Japan. Here's what's cooking
The Last-Mover Problem
A startup called Sennder is trying to bring an extremely tech-resistant industry into the age of apps
Tick Tock, TikTok
The US thinks the Chinese-owned social media app is a major national security risk. TikTok is running out of ways to avoid a ban
Cleaner Clothing Dye, Made From Bacteria
A UK company produces colors with less water than conventional methods and no toxic chemicals
Pumping Heat in Hamburg
The German port city plans to store hot water underground and bring it up to heat homes in the winter
Sustainability: Calamari's Climate Edge
Squid's ability to flourish in warmer waters makes it fitting for a diet for the changing environment
New Money, New Problems
In Naples, an influx of wealthy is displacing out-of-towners lower-income workers